Nusayba Bagegni, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Aptitude Health
    Date added:
    02/21/2024
    Date updated:
    04/01/2025
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Onclive
    Date added:
    02/21/2024
    Date updated:
    04/01/2025
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    NCCN
    Date added:
    02/21/2024
    Date updated:
    04/01/2025
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Curio Science
    Date added:
    02/21/2024
    Date updated:
    04/01/2025
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    MJH LifeSciences
    Date added:
    02/21/2024
    Date updated:
    04/01/2025
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Novartis
    Date added:
    02/21/2024
    Date updated:
    04/01/2025
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Sermonix Pharmaceuticals LLC
    Date added:
    02/21/2024
    Date updated:
    04/01/2025
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Biovica International
    Date added:
    02/21/2024
    Date updated:
    04/01/2025
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Pfizer
    Date added:
    02/21/2024
    Date updated:
    04/01/2025
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    AstraZeneca
    Date added:
    02/21/2024
    Date updated:
    04/01/2025

Pages

Return to Central Illinois Hematology Oncology Conference